Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $298.87 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $205.89 | 7 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $43.96 | 1 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.82 | 1 | $0 (2021) |
| CALLIDITAS THERAPEUTICS US INC. | $19.20 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $19.20 | 1 | CALLIDITAS THERAPEUTICS US INC. ($19.20) |
| 2021 | $29.82 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($29.82) |
| 2019 | $63.76 | 2 | E.R. Squibb & Sons, L.L.C. ($43.96) |
| 2017 | $186.09 | 6 | Allergan Inc. ($186.09) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/05/2022 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Autoimmune | ||||||
| 09/20/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $29.82 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $43.96 | General |
| 08/07/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/10/2017 | Allergan Inc. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/26/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/26/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $83.12 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2017 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: CARDIOVASCULAR | ||||||
About Ling Gao
Ling Gao is a Molecular Genetic Pathology healthcare provider based in Burr Ridge, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2013. The National Provider Identifier (NPI) number assigned to this provider is 1457797300.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ling Gao has received a total of $298.87 in payments from pharmaceutical and medical device companies, with $19.20 received in 2022. These payments were reported across 10 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($298.87).
Practice Information
- Specialty Molecular Genetic Pathology
- Location Burr Ridge, IL
- Active Since 05/20/2013
- Last Updated 05/03/2022
- Taxonomy Code 207ZP0007X
- Entity Type Individual
- NPI Number 1457797300
Products in Payments
- NAMZARIC (Drug) $126.76
- LINZESS (Drug) $55.99
- TRINTELLIX (Drug) $29.82
- BYSTOLIC (Drug) $23.14
- TARPEYO (Drug) $19.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.